[go: up one dir, main page]

DE60138552D1 - Peptide mit integrinbindungsmotiv und behandlungsmethoden für muskelkrankheiten - Google Patents

Peptide mit integrinbindungsmotiv und behandlungsmethoden für muskelkrankheiten

Info

Publication number
DE60138552D1
DE60138552D1 DE60138552T DE60138552T DE60138552D1 DE 60138552 D1 DE60138552 D1 DE 60138552D1 DE 60138552 T DE60138552 T DE 60138552T DE 60138552 T DE60138552 T DE 60138552T DE 60138552 D1 DE60138552 D1 DE 60138552D1
Authority
DE
Germany
Prior art keywords
motivation
peptides
integrin binding
treatment methods
binding motif
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60138552T
Other languages
English (en)
Inventor
Yoshinari Kumagai
Russell Wayne Blacher
Toshiyuki Yoneda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Big Bear Bio Inc
Original Assignee
Big Bear Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Big Bear Bio Inc filed Critical Big Bear Bio Inc
Application granted granted Critical
Publication of DE60138552D1 publication Critical patent/DE60138552D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4728—Calcium binding proteins, e.g. calmodulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Birds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
DE60138552T 2000-08-16 2001-08-14 Peptide mit integrinbindungsmotiv und behandlungsmethoden für muskelkrankheiten Expired - Lifetime DE60138552D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64103400A 2000-08-16 2000-08-16
US09/812,485 US6911425B2 (en) 2000-08-16 2001-03-19 Integrin binding motif containing peptides and methods of treating skeletal diseases
PCT/US2001/025542 WO2002014360A1 (en) 2000-08-16 2001-08-14 Integrin binding motif containing peptides and methods of treating skeletal diseases

Publications (1)

Publication Number Publication Date
DE60138552D1 true DE60138552D1 (de) 2009-06-10

Family

ID=27093672

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60138552T Expired - Lifetime DE60138552D1 (de) 2000-08-16 2001-08-14 Peptide mit integrinbindungsmotiv und behandlungsmethoden für muskelkrankheiten

Country Status (11)

Country Link
US (5) US6911425B2 (de)
EP (1) EP1309616B1 (de)
JP (3) JP4318246B2 (de)
CN (1) CN100488980C (de)
AT (1) ATE430165T1 (de)
AU (2) AU8649101A (de)
CA (1) CA2418716A1 (de)
DE (1) DE60138552D1 (de)
ES (1) ES2324153T3 (de)
MX (1) MXPA03001394A (de)
WO (1) WO2002014360A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU765349B2 (en) * 1998-05-18 2003-09-18 University College London A novel polypeptide hormone phosphatonin
PT1313440E (pt) * 2000-08-16 2008-10-22 Acologix Inc Produtos dentífricos que contêm um péptido que potencia o crescimento dos ossos
US6911425B2 (en) * 2000-08-16 2005-06-28 Acologix, Inc. Integrin binding motif containing peptides and methods of treating skeletal diseases
RU2385162C2 (ru) * 2003-12-01 2010-03-27 Арла Фудс Амба Применение остеопонтина в стоматологических композициях
EP1841444A4 (de) * 2005-01-07 2009-12-09 Acologix Inc Peptidformulierungen für periodontal- und dentalbehandlungen
EP1928491A4 (de) * 2005-07-18 2009-08-26 Acologix Inc Proteinformulierung zur förderung der bildung von hartem gewebe
CN100366302C (zh) * 2006-09-14 2008-02-06 清华大学 一种用于骨修复的矿化多肽材料及其制备方法
US7888462B2 (en) * 2007-01-22 2011-02-15 Acologix, Inc. Peptide composition and a method of promoting cartilage formation
JP5519121B2 (ja) * 2008-06-02 2014-06-11 学校法人東日本学園 新規ｒｇｄ含有ペプチドおよび象牙質再生剤、骨再生剤、歯周組織再生剤
MX347042B (es) * 2010-06-01 2017-04-10 Belle-Aire Fragrances Inc Producto y metodo para control de olor oral.
RU2503458C1 (ru) * 2012-08-27 2014-01-10 Сергей Васильевич Чуйкин Способ местного лечения и профилактики основных стоматологических заболеваний у детей с хронической почечной недостаточностью с применением жевательного фитосубстрата
JP6692676B2 (ja) * 2016-04-12 2020-05-13 学校法人東日本学園 ネフロネクチンを含むう蝕治療剤
CN106943311A (zh) * 2017-04-07 2017-07-14 缪来耿 一种用于预防和或治疗牙周炎的牙膏及其制备方法
US10849958B2 (en) * 2017-06-14 2020-12-01 Orthotrophix, Inc. Knee pain evaluation and management via WOMAC and KOOS systems
US11963996B2 (en) 2018-10-24 2024-04-23 Orthotrophix, Inc. Method of treating knee pain
CN109762069B (zh) * 2018-11-05 2022-01-14 广州领晟医疗科技有限公司 一种融合蛋白、其药物组合物及用途
CN111265652B (zh) * 2020-02-27 2023-06-27 广州领晟医疗科技有限公司 多肽在制备治疗缺血性脑血管疾病的药物中的应用
CN111358935B (zh) * 2020-02-27 2023-06-27 广州领晟医疗科技有限公司 多肽在制备抗肿瘤和/或抑制肿瘤转移药物中的用途及药物
CN111249446B (zh) * 2020-02-27 2023-06-27 广州领晟医疗科技有限公司 多肽及其盐的新用途
CN111569046B (zh) * 2020-04-14 2023-06-27 广州领晟医疗科技有限公司 多肽在制备治疗胰腺炎药物中的用途及含有其的药物
WO2022072156A1 (en) 2020-10-01 2022-04-07 Orthotrophix, Inc. Hard tissue therapeutics

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015628A (en) 1986-06-12 1991-05-14 The University Of Melbourne Anticariogenic phosphopeptides
US5120829A (en) * 1989-03-20 1992-06-09 La Jolla Cancer Research Foundation Hydrophobic attachment site for adhesion peptides
JPH0474132A (ja) * 1990-07-13 1992-03-09 Lion Corp 歯根膜ならびに歯槽骨組織再生修復促進剤
GB9203958D0 (en) 1992-02-25 1992-04-08 Norske Stats Oljeselskap Catalytic multi-phase reactor
US5981478A (en) 1993-11-24 1999-11-09 La Jolla Cancer Research Foundation Integrin-binding peptides
US6103709A (en) 1993-12-23 2000-08-15 The Regents Of The University Of California Therapeutically effective 1α,25-dihydroxyvitamin D3 analogs and methods for treatment of vitamin D diseases
US5770565A (en) * 1994-04-13 1998-06-23 La Jolla Cancer Research Center Peptides for reducing or inhibiting bone resorption
US6027592A (en) 1995-06-06 2000-02-22 Gillette Canada Inc. Dental floss
US6300062B1 (en) 1995-07-13 2001-10-09 Biora Ab Enamel matrix related polypeptide
US5837674A (en) 1996-07-03 1998-11-17 Big Bear Bio, Inc. Phosphopeptides and methods of treating bone diseases
WO1999008730A1 (en) 1997-08-15 1999-02-25 Children's Medical Center Corporation Osteopontin coated surfaces and methods of use
US6146655A (en) 1997-08-29 2000-11-14 Softy-Flex Inc. Flexible intra-oral bandage and drug delivery system
US6410248B1 (en) 1998-01-30 2002-06-25 Massachusetts Institute Of Technology General strategy for selecting high-affinity zinc finger proteins for diverse DNA target sites
WO1999043844A1 (en) * 1998-02-27 1999-09-02 The Trustees Of Columbia University In The City Of New York Reciprocal subtraction differential display
AU765349B2 (en) 1998-05-18 2003-09-18 University College London A novel polypeptide hormone phosphatonin
US6673900B2 (en) * 1999-11-04 2004-01-06 University College London Polypeptide hormone-phosphatonin
US6045780A (en) 1998-06-22 2000-04-04 Shemberg Marketing Corporation Toothpaste composition
AUPP893999A0 (en) * 1999-03-01 1999-03-25 Csl Limited Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis
US6145655A (en) * 1999-10-04 2000-11-14 Tsai; Allan Lens cleaning kit
US6790639B2 (en) 2000-02-29 2004-09-14 Pfizer Inc. Mammalian osteoregulins
US20020102641A1 (en) 2000-03-24 2002-08-01 Susan Schia Vi Oncogenic osteomalacia-related gene 1
JP3691484B2 (ja) 2000-07-19 2005-09-07 ザ ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム トロンビンペプチド誘導体による骨成長の刺激
US6911425B2 (en) * 2000-08-16 2005-06-28 Acologix, Inc. Integrin binding motif containing peptides and methods of treating skeletal diseases
PT1313440E (pt) * 2000-08-16 2008-10-22 Acologix Inc Produtos dentífricos que contêm um péptido que potencia o crescimento dos ossos

Also Published As

Publication number Publication date
US20020197267A1 (en) 2002-12-26
JP2004506654A (ja) 2004-03-04
US6911425B2 (en) 2005-06-28
US20090062201A1 (en) 2009-03-05
US20090042791A1 (en) 2009-02-12
CA2418716A1 (en) 2002-02-21
JP2011032286A (ja) 2011-02-17
US20050163728A1 (en) 2005-07-28
MXPA03001394A (es) 2004-12-13
CN1458935A (zh) 2003-11-26
ES2324153T3 (es) 2009-07-31
JP2007302673A (ja) 2007-11-22
US20070014742A1 (en) 2007-01-18
EP1309616A4 (de) 2004-12-08
ATE430165T1 (de) 2009-05-15
AU2001286491B2 (en) 2006-04-27
WO2002014360A1 (en) 2002-02-21
JP4318246B2 (ja) 2009-08-19
AU8649101A (en) 2002-02-25
EP1309616B1 (de) 2009-04-29
EP1309616A1 (de) 2003-05-14
US7160862B2 (en) 2007-01-09
CN100488980C (zh) 2009-05-20

Similar Documents

Publication Publication Date Title
DE60138552D1 (de) Peptide mit integrinbindungsmotiv und behandlungsmethoden für muskelkrankheiten
MX361694B (es) Fragmentos de peptidos para inducir sintesis de proteinas de matriz extra-celular.
ATE494902T1 (de) Ein huhn gnrh-ii analog zur verwendung in der reduktion des tumorzellwachstums
BR0309877A (pt) Peptìdeos estimuladores de tecido conectivo
ATE397626T1 (de) Rgd-angereicherte gelatine-ähnliche proteine mit verstärkter zellbindung
ATE467425T1 (de) Gezielte zufuhr von pharmazeutischen agenzien zu verletzten geweben
BRPI9908182C1 (pt) composições de proteína de matriz para cura de feridas
AU3576597A (en) Endoderm, cardiac and neural inducing factors
WO2004073616A3 (en) Elastin digest compositions and methods utilizing same
ATE401350T1 (de) Dentalzubereitungen enthaltend peptide, die das knochenwachstum fördern
MXPA02000465A (es) Derivados ciclopeptidicos como inhibidores de la integrina alfav beta6.
BR0009472A (pt) Antagonistas de lhrh com propriedades desolubilidade aperfeiçoadas
BR0111506A (pt) Complexos de droga macromoleculares e composições contendo os mesmos
WO2002058589A3 (en) Agents and methods for promoting bone growth
DE60025830D1 (de) Fusions-polypeptide zur gewebegeneration und wundheilung zur gezielten matrixanwendung
ATE193305T1 (de) Osteogene wachstums-oligopeptide und diese enthaltende pharmazeutische zusammensetzungen
RU2002135669A (ru) Олигопептиды
WO2006078464A3 (en) Formulations of peptides for periodontal and dental treatments
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
BR0014803A (pt) Peptìdeo, composição farmacêutica, uso de um ou mais dos peptìdeos, e, composição de diagnóstico
DK0811068T3 (da) Humane DNase I varianter
KR950703993A (ko) 치주 조직 질환 치료제(periodonal disease remedy)
ATE330971T1 (de) Polymere somatostatinderivate geeignet zur förderung des körperwachstums
ATE466025T1 (de) Physiologisch aktive peptide und medikamente, die diese enthalten
MX9800686A (es) Nueva proteina hmw humana mp52s.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition